Taylor, Cottrill, Erickson & Associates, Inc. Medexus Pharmaceuticals Inc CO Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

  • $340 Million
  • Q1 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
N/A
-35,000 Closed
0 $0
Q1 2022

May 03, 2022
BUY
N/A
10,000 Added 40.0%
35,000 $88,000
Q4 2021

Feb 03, 2022
SELL
N/A
-3,000 Reduced 10.71%
25,000 $50,000
Q3 2021

Oct 15, 2021
BUY
N/A
8,000 Added 40.0%
28,000 $66,000
Q2 2021

Jul 20, 2021
BUY
N/A
6,000 Added 42.86%
20,000 $118,000
Q1 2021

Apr 14, 2021
BUY
N/A
4,000 Added 40.0%
14,000 $88,000
Q3 2020

Oct 09, 2020
BUY
N/A
10,000 New
10,000 $29,000

About MEDEXUS PHARMACEUTICALS INC CO

MEDXF Quotes by TradingView
  • Ticker MEDXF
More about MEDXF
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email